《斑馬技術（Zebra）：2022年醫藥供應鏈愿景研究報告-技術主導的透明度提升醫藥供應鏈彈性（英文版）（14頁）.pdf》由會員分享，可在線閱讀，更多相關《斑馬技術（Zebra）：2022年醫藥供應鏈愿景研究報告-技術主導的透明度提升醫藥供應鏈彈性（英文版）（14頁）.pdf（14頁珍藏版）》請在三個皮匠報告上搜索。

1、Pharmaceutical Supply Chain Vision StudyTechnology-led Transparency Drives ResiliencyRising consumer expectations and industry requirements have precipitated supply chain improvements for new levels of agility,visibility and safety.2 zebra technologiesVision Study ReportPharmaceutical Supply ChainCo

2、ntents The Story in Numbers 3One-Minute Read 4Market Watch:The Impact of Public Health Crises and Increased Regulation 5Supply Chain Stability Heightens Patient Satisfaction 6Patients Want More Transparency and Education 7 Pharmaceutical Organizations Transition from Reactive to Predictive Operation

3、s 9 Increasing Confidence and Enabling Agility 10 Technology Investment Drives Supply Chain Resiliency 11 Regional Findings 13 Enabling a Safe,Stable and Reliable Supply Chain 14 About the Study Zebras Pharmaceutical Supply Chain Vision Study was conducted among a global audience of over 3,500 patie

4、nts and pharmaceutical industry decision-makers to evaluate perceived supply chain stability,gauge supply chain responsibility and trust in its entities,and identify needs for improving supply chain visibility and transparency.Respondents were surveyed in Asia Pacific,Europe,Latin America and North

5、America.Patients are adults with medical health issues requiring prescription medication or treatment that was filled at a pharmacy.Pharmaceutical industry decision-makers are executive-level leaders in healthcare,manufacturing,pharmacy retail,or transportation and logistics organizations who mainta

6、in operations in the pharmaceutical or biopharmaceutical supply chain.All data was collected and tabulated by third-party research firm Azure Knowledge Corporation.3 zebra technologiesVision Study ReportPharmaceutical Supply ChainThe Story in NumbersTop Trends:Comparing Patient Perceptions Against I

7、ndustry Decision-Maker PrioritiesNecessary Operational Changes to Avoid Future Business DisruptionsTechnology InvestmentsPatients Medication ConcernsEnterprise Leading ChallengesBuilding Trust Is Essential76%73%69%CostShortagesImproper dose due to labeling error46%Preventing substandard,fake or coun

8、terfeit medications40%Ensuring the right medications are delivered to patients on time and in full40%Quality assurance related to shipping,handling and temperature controlIndustry decision-makersPatients92%86%Average Trust Level in Pharmaceutical Supply Chain EntitiesIndustry decision-makers complet

9、ely trust entitiesPatients completely trust entities44%39%Most Trusted EntitiesIndustry decision-makers completely trust manufacturers and specialty pharmaciesPatients completely trust retail pharmacies49%47%Respondents agree technology investments provide a competitive edge in managing supply chain

10、 stability,security and traceability.Industry decision-makers agree:Diversify reliance on external suppliers Improve ability to adjust inventory to meet fluctuations in demandIdentify vulnerabilities,risks and failure points1234 zebra technologiesVision Study ReportPharmaceutical Supply Chainof ente

11、rprises agree supply chain visibility provides a clear competitive advantageof industry decision-makers are planning to increase investment in pharmaceutical manufacturing and supply chain monitoring96%92%Enterprises are continuing to leverage technology to improve supply chain operations.Examining

12、the Health of the Global Pharmaceutical Supply ChainThe COVID-19 pandemic upended businesses across nearly every category,profoundly altering how society does everything from going to work and school,shopping,getting medical care,and more.The pandemic also exposed vulnerabilities in the global pharm

13、aceutical supply chain.Retailers,healthcare providers and consumers alike shared concerns about potential drug shortages,quality issues and price volatility from the pharmaceutical sector as the worlds focus intensified on healthcare.Pharmaceutical enterprisesincluding manufacturers,transportation a

14、nd logistics providers,and healthcare organizationsrecognize the potential consequences of an inadequate supply chain and the importance of agility and resiliency.At the same time,each party in the supply chain grapples with the best manner to meet continually rising regulations from governments and

15、 industry agencies.Businesses are increasingly embracing technology to enhance quality,traceability and adherence to regulatory requirements.Industry leaders agree that technology holds great promise in helping them safeguard operations against future disruptions or new regulations,avoid or eliminat

16、e fines and chargebacks for medications,and ultimately better protect patients.In a sector where quality and efficacy are paramount,investment in enterprise technology supports the achievement of regulatory compliance as well as patient protection.A culture of data quality and integrity empowers and

17、 motivates change for a safer,more agile and more resilient supply chain that can stand up to future market disruptions.One-Minute ReadOne area of particular concern is the level of patient trust in the entities within the pharmaceutical supply chain.Overall,complete trust is low for both patients a

18、nd industry decision-makers.Industry decision-makers indicate that integration of enhanced track and trace solutions is key to strengthening supply chains and meeting patient expectations around medication authenticity,availability and quality assurance.5 zebra technologiesVision Study ReportPharmac

19、eutical Supply ChainMarket Watch:The Impact of Public Health Crises and Increased Regulation Current events and a shifting regulatory environment drive the need for supply chain enhancements and transparency from raw materials to manufacturer to pharmacy.While the COVID-19 pandemic posed outsized ch

20、allenges to the pharmaceutical industry,many of its supply chain issues were not new.Industry decision-makers recognize the value of enhanced trackability and traceability and the power of technology to help improve overall operations.Industry decision-makers acknowledge that operational improvement

21、s are necessary to meet an increased need for regulatory compliance and protect the public reputation of the enterprise in the long term.Meanwhile,the pandemic inspired new awareness in patients around the realities of global supply chain vulnerabilities.Patients want to know more about how their me

22、dications are manufactured,stored,handled and transported.With their health at stake,many patients do not tolerate issues with their prescriptions and have no trouble switching pharmacies,providers or brand names when unsatisfied with an experience.Industry decision-makers are also conscious of the

23、threats of an unreliable supply chain.Diversifying reliance on external suppliers and distributors,and the ability to adjust inventory to meet fluctuations in demand,top the list of solutions that decision-makers have realized they must pursue.Regulatory Compliance Is an IssueWhile most enterprises

24、across manufacturing,transportation and logistics,and healthcare are meeting or exceeding regulatory compliance,about one in 10 lags in meeting regulatory requirements.Despite success,it remains a potential threat for the pharmaceutical industry:About one-third of industry decision-makers surveyed r

25、ank compliance among their top five challenges facing their business today.Among the pharmaceutical industry verticals,manufacturing experiences the most significant lag in compliance.81%Regulatory delays (facility inspections,longer approval timelines,more in-depth inspections,increased quarantines

26、)Production limits Distribution and storage problemsShipping capacity constraintsTransportation delaysIndustry Decision-Makers Cite Top Five Supply Chain Issuesof patients reported heightened interest in how their medications are manufactured,handled,stored and transported because of the pandemic.12

27、3456 zebra technologiesVision Study ReportPharmaceutical Supply ChainSupply Chain Stability Heightens Patient SatisfactionPatients and industry decision-makers alike recognize the potential negative consequences of an unstable supply chain.They are aligned in their respective perceptions of the most

28、 significant risks posed if the pharmaceutical supply chain is not improved.Medication quality and efficacy due to improper storage,related principally to refrigeration and temperature control,top the list among both segments.Patients also cite perceived risk of illness and possible death due to con

29、taminated,tainted,falsified or counterfeit medications making their way into the supply chain.Issues with Prescription Medication Are CommonThe majority of patients surveyed report experiencing issues in the past with either purchasing or taking a prescription medication.Out of stocks and availabili

30、ty issues remain a crucial factor for patients in determining their overall satisfaction;this sentiment mirrors some of the major pain points also experienced in the retail sector in general.Patients Do Not Tolerate Issues with Their Medicationsof patients report experiencing issues with their medic

31、ationsreport making a change of provider,pharmacy or medication due to a poor experienceLeading Issues with Prescription Drugs Reported Among Patients32%needed medication that was unavailable or out of stock29%received only a partial amount due to unavailability at the time27%found the same product

32、at a lower price elsewhere22%did not receive on time or when neededGen XBaby BoomersMillennials34%20%39%76%70%Millennials Drive Pharmacys Digital TransformationAs digital natives age,more consumer behavior moves online.This reality,compounded by the impact of the COVID-19 pandemic,encouraged many pe

33、ople to explore new digital alternatives for everything from groceries to prescription drugs.By generation,millennials are the most likely to report experiencing a problem and making a change as a result;they are also the most likely to say they changed their pharmacy,with 21%among those experiencin

34、g a problem reporting they switched from brick-and-mortar stores to mail-order outlets.Respondents Who Changed Pharmacy Because of an Issue or Poor Experience with Medication or Treatment7 zebra technologiesVision Study ReportPharmaceutical Supply ChainOnly 48%of patients surveyed report being famil

35、iar with traceability at all,and less than two in 10 say they are very familiar.Although most patients are not very knowledgeable about the concept of pharmaceutical traceability,they are certainly impacted by the advantages track and trace offers,including:As digital natives and savvy consumers,mil

36、lennials have the highest level of familiarity compared to other generations.The differences across regions are striking,with consumers in Asia Pacific and Europe leading and North America reporting the lowest level of understanding.Patients Prioritize TraceabilityThough patients may not fully under

37、stand it in concept,the issues related to traceability are very important to all.Safeguarding product authenticity is a leading issue for patients,as is understanding the origin and medication journey end-to-end.The relationship between manufacturers and end consumers is largely a perceptual one,as

38、the two entities often only interact with healthcare providers or retail pharmacies as an intermediary.In patients minds,manufacturers,regulators and pharmaceutical enterprises are responsible for instilling public trust by ensuring that falsified or counterfeit medications do not enter the supply c

39、hain.There is a gap between patient and industry decision-maker perceptions regarding the industrys preparedness to manage traceability and transparency.While 84%of industry decision-makers say they are prepared,only 65%of patients feel the same.Patients Want More Transparency and Education76%of pat

40、ients and 86%of industry decision-makers agree that accessing supply chain information digitally makes it easier to learn more about medications.Information Is Vital Assurance that only authorized pharmaceuticals circulate in the legal supply chain Reduced risk posed by substandard,spurious,falsely

41、labeled,falsified and counterfeit(SSFFC)medications Prevention of dispensation of expired,prohibited or recalled medications8 zebra technologiesVision Study ReportPharmaceutical Supply ChainWho Is Responsible for Safety?The burden of responsibility for the safety of the pharmaceutical supply chain i

42、s shared among those who regulate,manufacture,dispense and administer medications.However,complete patient trust in these entities is relatively low.Improved collaboration between enterprises and regulatory agencies could inspire greater consumer trust while building an industry better prepared to a

43、ddress future public health crises.Responsibility for Medication SafetyHospitalsPharmaceutical ManufacturersPharmaceutical Enterprises*PharmaciesPhysicians/Nurses57%57%54%54%54%54%54%52%53%50%Enterprises realize the power of technology to enhance digital access to supply chain history.This informati

44、on is vital in educating patients and ultimately building trust.More patients need the benefits of digital education,as well as to learn more about their medications.*Pharmaceutical enterprises,other than manufacturers,include transportation and logistics providers and healthcare organizations.Pharm

45、aceutical ManufacturersPharmaceutical Enterprises*Physicians/NursesHospitalsPharmaciesAccording to Industry Decision-MakersAccording to Patients9 zebra technologiesVision Study ReportPharmaceutical Supply ChainOver half of both patients and industry decision-makers agree that investments in technolo

46、gy will provide a competitive edge in all key areas of the pharmaceutical business and across the end-to-end supply chain.Devices and technologies that track medications from raw materials to patients are top industry priorities.Realizing the Benefits of Modernized OperationsThe list of specific sol

47、utions trusted by industry decision-makers to improve traceability is led by technology that enables next-level visibility and traceability.Industry Decision-Makers Agree Devices and Technologies Help Improve Traceability Within the Supply ChainMeeting Digital Challenges to Build Long-Term Patient T

48、rustAs the online pharmacy category continues to grow,it creates challenges for the industry that must ensure the ease of arranging shipping and delivery and protecting temperature-sensitive medications throughout the journey and during the last mile to reach the patient.Technology enables faster an

49、d more secure fulfillment,whether online or from a traditional brick-and-mortar pharmacy.Clearer inventory visibility and powerful devices like thermal label printers are becoming increasingly important to deliver faster and more efficient fulfillment.Pharmaceutical Organizations Transition from Rea

50、ctive to Predictive Operations1 Temperature-sensitive labels and item/batch level monitors4 Mobile barcode labels and thermal printers2 Location technology5 Rugged scanners and the Internet of Things(IoT)and artificial intelligence(AI)technologies3 Temperature monitors and sensors10 zebra technologi

51、esVision Study ReportPharmaceutical Supply ChainIndustry decision-makers expect to shift to more responsive and predictive operations over the next five years as enterprises leverage real-time data to build more efficient and resilient supply chains.Pharmaceutical Industry Decision-Makers Describe t

52、he Shift in Supply Chain OperationsSupply chain optimizationTrack and monitor product temperatureMaintain drug efficacy,quality and stabilityRegulatory compliance on pharmaceutical safety guidelinesRisk reductions with proper handling,transportation and storage46%46%43%Areas Industry Decision-Makers

53、 Believe Technology Helps Improve TraceabilityIncreasing Confidence and Enabling Agility43%41%CurrentlyTrendingIn Five YearsSiloed and ReactiveOperating with legacy systems and devices7%10%StandardizedStandardizing to improve and streamline specific touchpoints and processes37%25%IntegratedIntegrati

54、ng enterprise-wide systems for greater visibility33%28%ResponsiveResponsive to digital signals throughout the supply chain15%22%PredictiveDigital transformation is the way of the business7%15%11 zebra technologiesVision Study ReportPharmaceutical Supply ChainForward-thinking pharmaceutical-sector en

55、terprises are harnessing the benefits of technology to improve operations and better protect patient health.Spending on enterprise devices and solutions is expected to increase,with a focus on pharmaceutical manufacturing and supply chain monitoring tools.Industry Decision-Makers Strategies Prioriti

56、ze IT InvestmentsLocation Technology Leads Future Deployment PlansEnhanced visibility is key to an agile and efficient supply chain.Location solutions,such as Radio Frequency Identification(RFID)and Real-Time Location Systems(RTLS),automatically sense the status of assets and inventory to provide re

57、al-time visibility across the facility.For pharmaceutical manufacturers and distributors,this can streamline production workflows and help to avoid shrink due to lost or potentially compromised products.Interestingly,76%of industry decision-makers say that they have already deployed location service

58、s technology or plan to in the next year.Device Implementation Plans to Manage the Pharmaceutical Supply Chain89%plan to increase IT spending within the next year,with 42%indicating the increase will be more than 10%.92%plan to increase IT spending on supply chain monitoring tools.Stationary Label P

59、rintersMobile Barcode Label or Thermal PrintersRugged ScannersRugged TabletsRugged Handheld Mobile Computers79%97%77%76%96%94%75%95%74%95%Over the Next Five YearsWithin the Next YearTechnology Investment Drives Supply Chain Resiliency12 zebra technologiesVision Study ReportPharmaceutical Supply Chai

60、nPriorities for Technology Investment Now and in the FutureThe combined solution of devices and software can enhance productivity,add invaluable visibility to the supply chain,and provide the security necessary to future-proof operations.Industry Decision-Makers Rate Top Five Benefits Technology Pro

61、vides1Ability to detect and respond to risk posed by counterfeit or substandard products2Keeping patients safe from compromised medications or other products3Improving team productivity and workflow conformity4Increasing product/asset visibility and utilization 5Enabling informed real-time decision-

62、making and regulatory complianceIndustry Decision-Makers Cite Technology Implementation Plans in Five Years97%Location Technology94%Temperature Monitors and Sensors94%Temperature-Sensitive Labels93%Prescriptive Analytics89%Machine Learning13 zebra technologiesVision Study ReportPharmaceutical Supply

63、 ChainRegional FindingsAsia Pacific About six in 10 patients in the Asia Pacific region believe delays in delivery(62%)and exposure to extreme temperatures(60%)are top issues among mail-order pharmacy usersthe highest compared to other regions.Latin AmericaPatients in Latin America do not tolerate i

64、ssues with their medications,as most report making a change due to a poor experience.With 87%of patients reporting a change in behavior,its the highest compared to all other regions.Europe Only 64%of patients and 74%of industry decision-makers in European countries agree that direct-to-patient deliv

65、ery of medications by mail is a convenient and consistently safe way to receive medicationsthe lowest agreement level regionally.North AmericaIn this region,51%of patients and 46%of industry decision-makers report that they completely trust retail or community pharmacies to ensure that medications a

66、nd other treatments are kept safethe highest level of trust among all regions.Vision Study ReportPharmaceutical Supply ChainBuild a Safe,Efficient Pharmaceutical Supply ChainTo learn how Zebra can help you digitalize your pharmaceutical supply chain for improved visibility,agility and business resil

67、ience,please visit: years have posed unprecedented challenges to global pharmaceutical supply chains.Despite disruptions,however,protecting the stability,security,quality and efficacy of medications and treatments remains the highest priority.To do so,and to protect patients and their business from

68、the impact of future crises,requires a shift to more predictive and responsive operations.Supply chain resiliency is on the horizon as more industry decision-makers are investing in track and trace technology to enable end-to-end visibility,streamline operations and achieve compliance.NA and Corpora

69、te Headquarters+1 800 423 Asia Pacific Headquarters+800 1302 EMEA H America Headquarters+1 866 230 ZEBRA and the stylized Zebra head are trademarks of Zebra Technologies Corp.,registered in many jurisdictions worldwide.All other trademarks are the property of their respective owners.2021 Zebra Techn

70、ologies Corp.and/or its affiliates.All rights reserved.Patient concerns align with the same challenges industry decision-makers are facing.Both segments understand the impact of unstable supply chains on the availability and efficacy of medications.Patients and industry decision-makers agree:The res

71、ponsibility for keeping the supply chain safe and secure is a collective effort shared between those who manufacture,distribute,administer and regulate medications.The impact of the pandemic increased both patients and enterprises awareness of the need for improvement across the pharmaceutical suppl

72、y chain globally.Increased trackability and traceability leads to risk reductions with proper handling,transportation and storage,particularly when it comes to temperature-sensitive medications.KEY TAKEAWAYSEnabling a Safe,Stable and Reliable Supply ChainAbout ZebraZebra(NASDAQ:ZBRA)empowers the front line of business in manufacturing,transportation and logistics,healthcare,retail,and other industries to achieve a performance edge.We deliver industry-tailored,end-to-end solutions that intelligently connect people,assets and data to help our customers make business-critical decisions.